![René Russo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
René Russo
Chief Executive Officer at
XILIO THERAPEUTICS, INC.
Net worth: 196 653 $ as of 30/05/2026
Profile
Founder of Adagio Therapeutics, Inc., René Russo presently holds the position of Chairman of Adagio Therapeutics, Inc. and President, Chief Executive Officer & Director at Xilio Therapeutics, Inc. Dr. Russo is also on the board of Celsius Therapeutics, Inc. and X4 Pharmaceuticals, Inc. (former President, Chief Executive Officer & Director). In her past career Dr. Russo was Director at Arsanis, Inc. and Vice President-Global Medical Affairs at Cubist Pharmaceuticals LLC. René Russo received a doctorate and an undergraduate degree from Rutgers Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/01/2026 | 23,245 ( 0.39% ) | 196 653 $ | 30/05/2026 |
René Russo active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Executive Officer | 21/05/2019 |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Director/Board Member | 30/04/2020 |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Chief Executive Officer | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Life Science Cares, Inc. | Director/Board Member | - |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Director/Board Member | - |
The Boston Ballet, Inc.
 The Boston Ballet, Inc. Media ConglomeratesConsumer Services Operates as an professional classical ballet company | Director/Board Member | - |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Director/Board Member | - |
Former positions of René Russo
| Companies | Position | End |
|---|---|---|
| INVIVYD, INC. | Founder | 30/06/2022 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of René Russo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
The Boston Ballet, Inc.
The Boston Ballet, Inc. Media ConglomeratesConsumer Services Operates as an professional classical ballet company | Consumer Services |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Life Science Cares, Inc. | |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- René Russo
